Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Healthcare Industry News STIMIT AG begins trial for noninvasive diaphragm stimulation device STIMIT AG, a medical technology innovator, has launched patient enrollment for its pivotal clinical trial assessing a noninvasive… byPallavi MadhirajuNovember 24, 2024